Monday, October 29, 2012
Forward Ventures is throwing its hat in the ring of life science VCs
pursuing an asset-based business model to generate returns. The firm is looking
to raise $100-$200 million for a new fund - Forward Medical Science Partners
(FoMS) L.P. - that will be solely dedicated to the investment strategy.
Stan Fleming, a managing member
and co-founder of Forward Ventures, said the fund is a break from the firm's
more traditional investment strategy